LEAVITT PARTNERS, LLC

Lobbying for SICKLE CELL DISEASE PARTNERSHIP · Alliance of patient advocates, plans, providers & manufacturers focused on federal policy.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $20,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Sickle cell disease focused legislation, federal funding, and federal programs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.